 |
市场调查报告书
商品编码
1638820
2024 - 2032 年远距药局市场机会、成长动力、产业趋势分析与预测Telepharmacy Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032 |
||||||
2023 年全球远距药局市场价值为 99 亿美元，预计 2024 年至 2032 年将以 10.4% 的年复合成长率(CAGR) 成长。它允许药剂师提供一系列服务，包括用药咨询、处方验证和患者监测，而无需患者亲自前往药房。这种方法有助于改善医疗保健的可近性，特别是在服务不足或农村地区，并简化药物管理。
市场成长是由对可获得的医疗保健解决方案的需求不断增长所推动的，特别是在传统药房服务稀缺的地区。透过使患者能够透过数位平台向执业药剂师咨询，远距药局消除了旅行的需要并增强了便利性。随着医疗保健提供者寻求更安全、远距的病患照护选择，COVID-19 大流行在促进远距药局的采用方面发挥了重要作用。
市场分为两个主要类别：软体和服务。软体细分市场将在 2023 年引领市场，预计将继续强劲成长，预测期内复合年增长率预计为 10.7%。这一增长归因于对支持远端咨询、处方管理和持续患者监测的先进远端药房平台的需求不断增长。这些平台提供安全视讯会议、即时资料共享以及药剂师和患者之间的无缝通讯等功能，有助于细分市场的扩展。
| 市场范围 | |
|---|---|
| 开始年份 | 2023年 |
| 预测年份 | 2024-2032 |
| 起始值 | 99 亿美元 |
| 预测值 | 236 亿美元 |
| 复合年增长率 | 10.4% |
对医疗保健 IT 的投资不断增加以及对资料隐私合规性的需求不断增长是软体领域的关键驱动力。随着越来越多的医疗保健服务转向数位平台，远距药局软体在提高药物依从性、患者参与度和整体药物服务可近性方面发挥着至关重要的作用。
从最终用户来看，远距药局市场分为医院药局、零售药局和其他用户。由于越来越多地使用远端药房来管理远端咨询、药物管理和患者支持，医院药房在 2023 年占据了最大的市场份额。此细分市场受益于为农村和服务欠缺地区的患者提供护理的能力，同时减少患者前往服药的需要。
北美的远距药局市场尤其强劲，医疗基础设施、先进技术和有利法规的大量投资推动了市场成长。对远距医疗服务的需求，特别是在农村社区，持续成长，进一步支持了远距药局在整个地区的扩张。随着数位健康解决方案受到关注，远距药局正在成为现代医疗保健服务的重要组成部分。
目录
第 1 章：方法与范围
第 2 章：执行摘要
第 3 章：产业洞察
- 产业生态系统分析
- 产业影响力
- 成长动力
- 远距医疗需求增加
- 慢性病盛行率上升
- 支持性法规政策
- 电信技术和软体解决方案不断进步
- 产业陷阱与挑战
- 患者意识有限
- 资料安全问题
- 成长动力
- 成长潜力分析
- 未来市场趋势
- 监管环境
- 技术景观
- 波特的分析
- PESTEL分析
第 4 章：竞争格局
- 介绍
- 公司市占率分析
- 公司矩阵分析
- 主要市场参与者的竞争分析
- 竞争定位矩阵
- 战略仪表板
第 5 章：市场估计与预测：按软体和服务划分，2021 - 2032 年
- 主要趋势
- 软体
- 本地
- 基于网路/基于云端
- 服务
- 远程点胶
- 远距患者咨询
- 远端订单输入审核
- 药物治疗监测
- 其他服务
第 6 章：市场估计与预测：依最终用途，2021 - 2032 年
- 主要趋势
- 医院药房
- 零售药局
- 其他最终用户
第 7 章：市场估计与预测：按地区，2021 - 2032
- 主要趋势
- 北美洲
- 我们
- 加拿大
- 欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 荷兰
- 亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
第 8 章：公司简介
- AZOVA
- Cardinal Health
- CarepathRx
- CPS Solutions
- Indispensable Health
- Infinipharm
- Medication Review
- OSP
- Outcomes
- PipelineRx
- Right ePharmacy
- Zane Networks
The Global Telepharmacy Market was valued at USD 9.9 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.4% from 2024 to 2032. Telepharmacy refers to the use of technology to deliver pharmaceutical services remotely. It allows pharmacists to provide a range of services, including medication counseling, prescription verification, and patient monitoring, without requiring patients to visit the pharmacy in person. This approach helps improve access to healthcare, especially in underserved or rural regions, and streamlines medication management.
The market growth is driven by the increasing demand for accessible healthcare solutions, particularly in areas where traditional pharmacy services are scarce. By enabling patients to consult with licensed pharmacists via digital platforms, telepharmacy eliminates the need for travel and enhances convenience. The COVID-19 pandemic played a significant role in boosting telepharmacy adoption as healthcare providers sought safer, remote options for patient care.
The market is divided into two primary categories: software and services. The software segment led the market in 2023 and is expected to continue its strong growth, with a projected CAGR of 10.7% during the forecast period. This growth is attributed to the rising demand for advanced telepharmacy platforms that support remote consultations, prescription management, and continuous patient monitoring. These platforms offer features like secure video conferencing, real-time data sharing, and seamless communication between pharmacists and patients, contributing to segment expansion.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $9.9 Billion |
| Forecast Value | $23.6 Billion |
| CAGR | 10.4% |
The increasing investment in healthcare IT and the growing need for data privacy compliance are key drivers for the software segment. As more healthcare services transition to digital platforms, telepharmacy software plays a crucial role in improving medication adherence, patient engagement, and overall accessibility to pharmaceutical services.
In terms of end users, the telepharmacy market is segmented into hospital pharmacies, retail pharmacies, and other users. Hospital pharmacies accounted for the largest market share in 2023, driven by their growing use of telepharmacy to manage remote consultations, medication administration, and patient support. This segment benefits from the ability to provide care to patients in rural and underserved areas while reducing the need for patients to travel for medications.
The telepharmacy market is particularly strong in North America, where significant investments in healthcare infrastructure, advanced technology, and favorable regulations drive market growth. The demand for remote healthcare services, particularly in rural communities, continues to rise, further supporting the expansion of telepharmacy across the region. As digital health solutions gain traction, telepharmacy is becoming a vital component of modern healthcare delivery.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increased demand for remote healthcare
- 3.2.1.2 Rising chronic disease prevalence
- 3.2.1.3 Supportive regulations and policies
- 3.2.1.4 Growing technology advancement in telecommunication technologies and software solutions
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Limited awareness among patients
- 3.2.2.2 Data security concerns
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Future market trends
- 3.5 Regulatory landscape
- 3.6 Technology landscape
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Software & Services, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Software
- 5.2.1 On-premises
- 5.2.2 Web-based/cloud-based
- 5.3 Services
- 5.3.1 Remote dispensing
- 5.3.2 Remote patient counseling
- 5.3.3 Remote order-entry review
- 5.3.4 Drug therapy monitoring
- 5.3.5 Other services
Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Hospital pharmacies
- 6.3 Retail pharmacies
- 6.4 Other end users
Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Netherlands
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
Chapter 8 Company Profiles
- 8.1 AZOVA
- 8.2 Cardinal Health
- 8.3 CarepathRx
- 8.4 CPS Solutions
- 8.5 Indispensable Health
- 8.6 Infinipharm
- 8.7 Medication Review
- 8.8 OSP
- 8.9 Outcomes
- 8.10 PipelineRx
- 8.11 Right ePharmacy
- 8.12 Zane Networks
